Canada.altasciences.com

An Overview of Health Canada's CTA Process Altasciences

WEBWatch this podcast in which Altasciences' regulatory experts share key insights on Health Canada's Clinical Trial Application (CTA) regulatory submission process, including answers to your most common questions. WATCH PODCAST. Altasciences’ Canadian clinical facility consists of seven Phase I units. We conduct over 100 trials every year in

Actived: 8 days ago

URL: https://canada.altasciences.com/e-bulletin/overview-health-canadas-cta-process

What Effect Will the New NIH Policy Have On Multi-Site Research

WEBIn June 2016, the National Institutes of Health (NIH) released a new policy on the use of a single institutional review board for multi-site clinical research. According to the policy, the goal of this policy is to “enhance and streamline the IRB review process in the context of multi-site research so that research can proceed as effectively and expeditiously as …

Category:  Health Go Health

Clinical Research Services

WEBClinical Research Services for Early Phase Drug Development. Not all CROs are created equal. Your project deserves the most efficient, high quality clinical research services, to advance through the early phases of drug development quickly and seamlessly. Advancing your drug candidate smoothly to proof of concept is what we do best.

Category:  Health Go Health

About Us Integrated Mid-Size CRO CDMO Altasciences

WEBOur Purpose. Our purpose is to help you research and develop potentially life-saving therapeutics — and get you there faster, with integrated CRO/CDMO services, always moving in unison for maximum efficiency. Our commitment to quality, excellence, integrity, and respect help us deliver big impact with a personal touch. 3:59.

Category:  Health Go Health

Altasciences Acquires Sinclair Research and Continues to Expand

WEBLaval, Quebec, January 4, 2022 – Altasciences, an integrated CRO/CDMO offering pharmaceutical and biotechnology companies a seamless solution to early-stage drug development from lead candidate selection to clinical proof of concept, announced today the completed acquisition of Sinclair Research, a preclinical CRO located in the Midwest. . …

Category:  Health Go Health

Meet Your Altascientists

WEB• Emily Griffith, DVM, Associate Director, Surgical Services • Dr. Lisa Biegel, Senior Scientific Director, Preclinical Services • Andy Fecht, Director of Environmental Health and Safety

Category:  Health Go Health

Bioanalytical Services Altasciences

WEBAltasciences' bioanalytical labs excel in assay development, backed by a team of over 260 scientists. Our capabilities span mass spectrometry, ligand binding assays, microsampling, and more, with a robust database of 685+ assays. Specializing in diverse biological matrices and state-of-the-art laboratories, we are fully equipped to support

Category:  Health Go Health

Our Solutions Altasciences

WEBDevelopment Programs. Early-Phase Drug Development. Small Molecule Solutions. Large Molecule Solutions. We have been very pleased with their record of timely recruitment, including ensuring an inventory of back-up study participants. Hélène Dulude, B.Pharm., Ph.D., Director, Clinical Development, Locemia Solutions ULC.

Category:  Health Go Health

NEWS Altasciences

WEBNews Insights Care: Canada's Most Visionary Male Leaders in Healthcare to Follow 2023 — Chris Perkin, CEO at Altasciences. Nov 30, 2023

Category:  Health Go Health

THE ADVANTAGES OF CONDUCTING EARLY PHASE CLINICAL …

WEBaltasciences.com The Altascientist2 To initiate a clinical trial in Canada, a Clinical Trial Application (CTA) specific to the given study is submitted to Health Canada (HC) for approval, along with concurrent

Category:  Health Go Health

FDA GUIDANCE ENSURES NEW DRUGS ARE STUDIED FOR …

WEBwww.altasciences.com The Altascientist Reducing the incidence of motor vehicle accidents (MVAs) that occur because of drug-impaired driving is a public health priority.

Category:  Health Go Health

Drug Development Timelines: Canada's 30-Day Regulatory Review

WEBAccording to the new EU-CTR regulations, clinical trial review timelines may vary from 60 to 106 days for Part I Assessment (with a comparable timeline for Part II Assessment), in comparison to the Health Canada default 30-calendar-day review period. Health Canada also has a seven-day turnaround review for eligible comparative, single dose BA

Category:  Health Go Health

2021 Year in Review Altasciences

WEBIn 2021, you did incredible things — and we are grateful to have been part of your journey.

Category:  Health Go Health

BLOG Altasciences

WEBInside The Altascientist: The Benefits of PCR for Your Gene Therapy Programs. Apr 16, 2024. Blog.

Category:  Health Go Health

Up Close and Personal with Dr. Morelli, MD Altasciences

WEBDr. Morelli has over 30 years of medical and clinical experience and 25 years of experience in clinical research. He is a clinical-academic Gastroenterologist at the McGill University Health Network and an Associate Professor of Medicine at McGill University, involved in medical training of students, residents, and specialty fellows.

Category:  Medical,  Medicine Go Health

Tackling Early Phase Development Challenges with Effective …

WEB1. First-in-human (FIH) trials in the early phases of drug development represent a critical milestone in the approval of medicines. Their purpose is to study the human pharmacology pharmac, okinetics (PK) and pharmacodynamics (PD), tolerability, and safety of an investigational medicinal product (IMP) having already gone through preclinical

Category:  Medicine Go Health